RNA Interference (RNAi)-Based Therapeutics: Delivering on the Promise?

被引：257
|
作者：
Bobbin, Maggie L. [1 ,2 ]
Rossi, John J. [3 ]
机构：
[1] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA
[2] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA
[3] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA
来源：
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 | 2016年 / 56卷
关键词：
clinical trials; siRNA; miRNA; shRNA; dsiRNA; DOUBLE-STRANDED-RNA; CHRONIC HEPATITIS-B; SIRNA DELIVERY; VIRUS; STRATEGIES; EFFICACY;
D O I：
10.1146/annurev-pharmtox-010715-103633
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
A resurgence in clinical trials using RNA interference (RNAi) occurred in 2012. Although there were initial difficulties in achieving efficacious results with RNAi without toxic side effects, advances in delivery and improved chemistry made this resurgence possible. More than 20 RNAi-based therapeutics are currently in clinical trials, and several of these are Phase III trials. Continued positive results from these trials have helped bolster further attempts to develop clinically relevant RNAi therapies. With a wide variety of disease targets to choose from, the first RNAi therapeutic to be clinically approved is not far off. This review covers recently established and completed clinical trials.
引用
收藏
页码：103 / 122
页数：20
相关论文
共 50 条
  • [1] Delivering the promise of RNA therapeutics
    [J]. Nature Medicine, 2019, 25 : 1321 - 1321
  • [2] Delivering the promise of RNA therapeutics
    不详
    [J]. NATURE MEDICINE, 2019, 25 (09) : 1321 - 1321
  • [3] Delivery strategies for RNA interference (RNAi) based therapeutics
    Manoharan, Muthiah
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [4] RNA interference (RNAi)-based therapeutics for treatment of rare neurologic diseases
    Germain, Noelle D.
    Chung, Wendy K.
    Sarmiere, Patrick D.
    [J]. MOLECULAR ASPECTS OF MEDICINE, 2023, 91
  • [5] The challenge of delivering RNA-interference therapeutics to their target cells
    Bianca Nogrady
    [J]. Nature, 2019, 574 (7778) : S8 - S9
  • [6] Safety and effectiveness of interference RNA (RNAi) based therapeutics in cardiac failure: A systematic review
    Saddique, Muhammad Nabeel
    Qadri, Maria
    ul Ain, Noor
    Farhan, Eesha
    Shahid, Fatima
    Benyamin, Javeria
    Bashir, Muhammad Atif
    Jain, Hritvik
    Iqbal, Javed
    [J]. HEART & LUNG, 2024, 68 : 298 - 304
  • [7] Delivering the promise of small ncRNA therapeutics
    Miller, Andrew D.
    [J]. THERAPEUTIC DELIVERY, 2014, 5 (05) : 569 - 589
  • [8] Delivering the promise of miRNA cancer therapeutics
    Pereira, Diane M.
    Rodrigues, Pedro M.
    Borralho, Pedro M.
    Rodrigues, Cecilia M. P.
    [J]. DRUG DISCOVERY TODAY, 2013, 18 (5-6) : 282 - 289
  • [9] Delivering RNAi therapeutics: From discovery to applications
    Manoharan, Muthiah
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [10] CARB 46-Delivering RNAi Therapeutics
    Maraganore, John
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
12345